Exothera
Martin Van Den Spiegel is a seasoned professional in the biopharmaceutical industry, currently serving as a Senior Production Support Specialist at Exothera since July 2021. Responsibilities include environmental monitoring, maintaining clean zones, drafting standard operating procedures, and managing sterilization equipment qualifications. Prior experience at UCB involved roles in material preparation and filling line operations within the injectable department, alongside certifications in Grade B compliance and first aid training from Croix Rouge de Belgique. Martin's educational background includes certifications in biopharmaceutical operations and formal education in management and education.
Exothera
Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660